The Taa1 restriction enzyme provides a simple means to identify the Q368STOP mutation of the myocilin gene in primary open angle glaucoma

Am J Ophthalmol. 2001 Apr;131(4):510-1. doi: 10.1016/s0002-9394(00)00812-6.

Abstract

Purpose: To identify a rapid and reliable method to detect the Glutamine 368 STOP (Q368STOP) disease-predisposing allele of the myocilin gene associated with adult onset, primary, open-angle glaucoma.

Methods: Individuals with the Q368STOP mutation of the myocilin gene were identified from a cohort of primary open-angle glaucoma patients from Tasmania and subjected to Taa1 restriction digestion.

Results: In the Tasmanian family presented, screening with the Taa1 restriction enzyme successfully confirmed identification of all individuals with the Q368STOP mutation.

Conclusions: The use of the Taa1 restriction enzyme offers a relatively simple, rapid, and reproducible technique that could be applied to detect the Q368STOP mutation of the myocilin gene.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Codon, Terminator / genetics*
  • Cytoskeletal Proteins
  • DNA Mutational Analysis / methods*
  • DNA Primers / chemistry
  • DNA Restriction Enzymes*
  • Eye Proteins / genetics*
  • Female
  • Gene Amplification
  • Glaucoma, Open-Angle / genetics*
  • Glycoproteins / genetics*
  • Humans
  • Mutation*
  • Pedigree
  • Polymerase Chain Reaction
  • Restriction Mapping

Substances

  • Codon, Terminator
  • Cytoskeletal Proteins
  • DNA Primers
  • Eye Proteins
  • Glycoproteins
  • trabecular meshwork-induced glucocorticoid response protein
  • DNA Restriction Enzymes